Ingrid Holm | Medical Services
Specialties
- Achondroplasia
- Androgen Insensitivity
- Birth Defects and Congenital Anomalies
- Bowlegs
- Delayed Puberty / Delayed Sexual Development
- Ehlers-Danlos Syndrome
- Fibrous Dysplasia
- Genetic Disorders
- Growth Hormone Deficiency
- Growth Problems
- Hyperparathyroidism
- Hyperthyroidism
- Hypocalcemia
- Hypopituitarism
- Hypothyroidism
- Osteogenesis Imperfecta
- Precocious Early Puberty
- Premature Adrenarche
- Sudden Infant Death Syndrome SIDS
- Turner Syndrome
Programs & Services
- Behavioral Health, Endocrinology, Gynecology, Urology (BEING-U)
- Bone Health Program
- Endocrinology
- Genetics and Genomics
- Robert’s Program
Languages
- English
- Swedish
Ingrid Holm | Education
Undergraduate School
Psychology
Brown University
1979, Providence, RI
Medical School
University of California, Los Angeles, School of Medicine
1985, Los Angeles, CA
Internship
Pediatrics
Boston Children's Hospital
1986, Boston, MA
Residency
Pediatrics
Boston Children's Hospital
1988, Boston, MA
Fellowship
Genetics and Pediatric Endocrinology
Boston Children's Hospital
1992, Boston, MA
Graduate School
MPH
Harvard School of Public Health
2003, Boston, MA
Ingrid Holm | Certifications
- American Board of Medical Genetics and Genomics (Clinical Genetics)
- American Board of Pediatrics (Endocrinology)
Ingrid Holm | Professional History
Ingrid A. Holm, MD, MPH is a pediatric geneticist and endocrinologist at Boston Children’s Hospital (BCH), Professor of Pediatrics at Harvard Medical School (HMS), and a member of the HMS Center for Bioethics. She received her M.D. from the University of California, Los Angeles, and she completed her residency in pediatrics and her fellowships in genetics and pediatric endocrinology at BCH. In 2003 she completed the Harvard Pediatric Health Services Research Fellowship and received her M.P.H. in Clinical Effectiveness at the Harvard School of Public Health. She has a certificate in Pediatric Bioethics.
Dr. Holm focuses on the Ethical, Legal, and Social Implications (ELSI) of genomics, and in rare disease research. She studies the impact of integrating genetic sequencing into newborn screening, the impact of implementation of genomic medicine on patients and providers, and the ethics of therapies for ultrarare diseases. She is Associate Director of Robert’s Program in Sudden Unexpected Death in Pediatrics (SUDP), to identify genetic contributions to SUDP. She was elected to the Society for Pediatric Research, is a Fellow of the American Academy of Pediatrics (AAP) and a Fellow of the American College of Medical Genetics and Genomics (ACMG). She chairs the BCH IRB. Dr. Holm’s primary clinical interests are in pediatric bone disease and genetic conditions that lead to disorders of sex development.